Detalhe da pesquisa
1.
Tenecteplase for Stroke at 4.5 to 24 Hours with Perfusion-Imaging Selection.
N Engl J Med
; 390(8): 701-711, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38329148
2.
Tenecteplase for Stroke at 4.5 to 24 Hours. Reply.
N Engl J Med
; 390(18): 1729, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38718370
3.
Thrombolysis in Mild Stroke: A Comparative Analysis of the PRISMS and MaRISS Studies.
Stroke
; 52(10): e586-e589, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496619
4.
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
JAMA
; 320(2): 156-166, 2018 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998337
5.
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke.
J Clin Pharmacol
; 63(2): 197-209, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36278839
6.
A Phase III, prospective, double-blind, randomized, placebo-controlled trial of thrombolysis in imaging-eligible, late-window patients to assess the efficacy and safety of tenecteplase (TIMELESS): Rationale and design.
Int J Stroke
; 18(2): 237-241, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262424
7.
Choosing the Correct "-ase" in Acute Ischemic Stroke: Alteplase, Tenecteplase, and Reteplase.
Adv Emerg Nurs J
; 41(3): 271-278, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31356253
8.
Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
Expert Opin Drug Saf
; 18(2): 87-96, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712409
9.
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design.
Int J Stroke
; 13(6): 654-661, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29570044